Debrecen, Hungary

Edit Arvai Nagyne

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Biogal Gyogyszergyar Rt.. Active years: 2002-2004.


% Patents Active = 50.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2002-2004

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Edit Arvai Nagyne: Innovator in Statin Recovery Processes

Introduction

Edit Arvai Nagyne is a prominent inventor based in Debrecen, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the recovery of statin compounds. With a total of two patents to her name, her work has the potential to impact the production of important medications.

Latest Patents

Her latest patents include a process for recovering statin compounds from a fermentation broth. This patent describes a composition comprising pravastatin sodium that is substantially free of pravastatin lactone. Additionally, she has developed a novel process for recovering a compound from a fermentation broth. This process includes stages such as forming an enriched solution of the compound by extraction, obtaining a salt of the compound from the enriched solution, purifying the salt, and trans-salifying it to a metal salt of the compound.

Career Highlights

Edit Arvai Nagyne is associated with Biogal Gyogyszergyar Rt., where she continues to innovate in her field. Her work is crucial in enhancing the efficiency of pharmaceutical production processes.

Collaborations

She collaborates with notable colleagues, including Vilmos Keri and Lajos Deak, who contribute to her research and development efforts.

Conclusion

Edit Arvai Nagyne's contributions to the field of pharmaceuticals, particularly in the recovery of statin compounds, highlight her innovative spirit and dedication to improving medication production. Her patents reflect her expertise and commitment to advancing pharmaceutical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…